We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pulmonary Embolism in Exacerbations of Chronic Obstructive Pulmonary Disease

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01318174
First Posted: March 18, 2011
Last Update Posted: July 8, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Aleksander Talgøy Holten, Sykehuset Innlandet HF
  Purpose
The purpose of this study is to determine the prevalence of pulmonary embolism in our population of Chronic Obstructive Pulmonary Disease (COPD) patients admitted to hospital with dyspnea. The patients will undergo investigation for pulmonary embolism, according to current guidelines.

Condition
Pulmonary Embolism Chronic Obstructive Pulmonary Disease

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Prevalence of Pulmonary Embolism in Exacerbations of Chronic Obstructive Pulmonary Disease

Resource links provided by NLM:


Further study details as provided by Aleksander Talgøy Holten, Sykehuset Innlandet HF:

Primary Outcome Measures:
  • Prevalence of pulmonary embolism in exacerbations of COPD [ Time Frame: one year ]

Enrollment: 38
Study Start Date: April 2011
Study Completion Date: April 2013
Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with known or suspected COPD admitted with an exacerbation of unknown aetiology
Criteria

Inclusion Criteria:

  • known or suspected COPD
  • COPD-exacerbation

Exclusion Criteria:

  • other causes of dyspnea
  • unable to perform CT pulmonary angio (contrast allergy, pregnancy)
  • already included in the study (each patient included only once)
  • use of anticoagulants
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01318174


Locations
Norway
Sykehuset Innlandet
Lillehammer, Oppland, Norway, 2381
Sponsors and Collaborators
Sykehuset Innlandet HF
Investigators
Principal Investigator: Aleksander T Holten, PhD Sykehuset Innlandet HF
  More Information

Responsible Party: Aleksander Talgøy Holten, MD, Sykehuset Innlandet HF
ClinicalTrials.gov Identifier: NCT01318174     History of Changes
Other Study ID Numbers: LE-KE
First Submitted: March 17, 2011
First Posted: March 18, 2011
Last Update Posted: July 8, 2014
Last Verified: July 2014

Keywords provided by Aleksander Talgøy Holten, Sykehuset Innlandet HF:
Pulmonary embolism
Pulmonary Disease, Chronic Obstructive

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Embolism
Pulmonary Embolism
Respiratory Tract Diseases
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases